Cizzle Biotechnology (UK) Top Management
CIZ Stock | 1.75 0.05 2.78% |
Cizzle Biotechnology employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of Cizzle Biotechnology's management performance can provide insight into the firm performance.
Allan Syms Chairman Executive Chairman |
Cizzle |
Cizzle Biotechnology Management Team Effectiveness
The company has return on total asset (ROA) of (0.3172) % which means that it has lost $0.3172 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5781) %, meaning that it generated substantial loss on money invested by shareholders. Cizzle Biotechnology's management efficiency ratios could be used to measure how well Cizzle Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cizzle Biotechnology's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 270.9 K, whereas Total Current Assets are forecasted to decline to about 1.5 M.As of December 17, 2024, Common Stock Shares Outstanding is expected to decline to about 338.1 M. In addition to that, Net Loss is expected to decline to about (861.8 K)
Cizzle Biotechnology Workforce Comparison
Cizzle Biotechnology Holdings is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1.22 Million. Cizzle Biotechnology adds roughly 4.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Cizzle Biotechnology Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Cizzle Biotechnology Price Series Summation is a cross summation of Cizzle Biotechnology price series and its benchmark/peer.
Cizzle Biotechnology Notable Stakeholders
A Cizzle Biotechnology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cizzle Biotechnology often face trade-offs trying to please all of them. Cizzle Biotechnology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cizzle Biotechnology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Allan Syms | Executive Chairman | Profile | |
Pr Coverley | Founder Director | Profile | |
Nigel Lee | Finance Director | Profile | |
Morgan Williams | Head Observer | Profile |
About Cizzle Biotechnology Management Performance
The success or failure of an entity such as Cizzle Biotechnology often depends on how effective the management is. Cizzle Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cizzle management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cizzle management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cizzle Biotechnology is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the presentation of Cizzle Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cizzle Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cizzle Biotechnology's management manipulating its earnings.
Cizzle Biotechnology Workforce Analysis
Traditionally, organizations such as Cizzle Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cizzle Biotechnology within its industry.Cizzle Biotechnology Manpower Efficiency
Return on Cizzle Biotechnology Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 440.8K | |
Net Loss Per Executive | 440.8K | |
Working Capital Per Employee | 376.8K | |
Working Capital Per Executive | 376.8K |
Complementary Tools for Cizzle Stock analysis
When running Cizzle Biotechnology's price analysis, check to measure Cizzle Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cizzle Biotechnology is operating at the current time. Most of Cizzle Biotechnology's value examination focuses on studying past and present price action to predict the probability of Cizzle Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cizzle Biotechnology's price. Additionally, you may evaluate how the addition of Cizzle Biotechnology to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |